02/07/2026
Psychedelics are catching on in the United States, but not always to reach another plane of reality, a new study says. An estimated 10 million U.S. adults microdosed psilocybin, L*D or M**A in 2025. Researchers found that microdosing (taking a very small dose without the intention of reaching an altered state of consciousness) is common among people who use psychedelics. People who microdose do so for many reasons, including managing symptoms of anxiety and depression or improving mood and creativity. Psychedelics are being examined for a wide array of potential mental health benefits, including as a promising treatment for mood disorders, and PTSD. The drugs remain prohibited at the federal level, but some states and cities have passed laws allowing their use for medicinal purposes.